TrialThe Journal of clinical endocrinology and metabolism2025

Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.

Bart L Clarke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.